XGBoost-based machine learning test improves the accuracy of hemorrhage prediction among geriatric patients with long-term administration of rivaroxaban
Abstract Background Hemorrhage is a potential and serious adverse drug reaction, especially for geriatric patients with long-term administration of rivaroxaban. It is essential to establish an effective model for predicting bleeding events, which could improve the safety of rivaroxaban use in clinic...
Main Authors: | Cheng Chen, Chun Yin, Yanhu Wang, Jing Zeng, Shuili Wang, Yurong Bao, Yixuan Xu, Tongbo Liu, Jiao Fan, Xian Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12877-023-04049-z |
Similar Items
-
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
by: Stephanie Müller, et al.
Published: (2022-10-01) -
A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01) -
Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
by: Abbas Ghaysouri, et al.
Published: (2020-09-01) -
Evaluation of the Hemostatic Effect of an Innovative Tissue Adhesive during Extraction Therapy under Rivaroxaban in a Rodent Model
by: Marius Heitzer, et al.
Published: (2023-06-01) -
A rare complication in a patient taking rivaroxaban: Alveolar hemorrhage
by: Salih Kılıç, et al.
Published: (2018-01-01)